Furthermore, to evaluate the effects of Gankyrin downregulation on tumor biological behavior, we used a plasmid vector to express a short-hairpin RNA (shRNA) targeted against Gankyrin mRNA in HepG2 human HCC cells (ATCC, Rockville, MD). This evidence concerns the gene PSMD10 and hepatocellular carcinoma.